Literature DB >> 24745620

A NSQIP risk assessment for thyroid surgery based on comorbidities.

Christa R Abraham1, Ashar Ata2, Carrie B Carsello2, Tiffany L Chan2, Steven C Stain2, Todd D Beyer2.   

Abstract

BACKGROUND: Thyroid surgery is associated with low mortality and morbidity and often is performed in an ambulatory setting. The majority of patients undergoing thyroidectomy have an uncomplicated outcome, but common comorbidities may increase mortality and morbidity. Due to low complication rates, studies using single surgeon or single institutional data to identify risk factors for adverse outcomes may be limited by inadequate patient volume. STUDY
DESIGN: This retrospective cohort study used data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). The study group included all thyroidectomy patients over a 6-year period (2005 to 2010). Common patient comorbidities were identified and analyzed using logistic regression. Risk of adverse outcomes was calculated for single and multiple comorbidities. Statistical significance was set at p < 0.05.
RESULTS: The study group included 38,577 consecutive patients. Thirty-day mortality and postoperative morbidity were 0.06% and 1.49%, respectively. The risk factors independently associated with morbidity included hypertension, diabetes, advanced age greater than 70 years, COPD, dialysis, malignant thyroid disease, and surgical approach (total thyroidectomy). Substernal thyroidectomy, hypertension, diabetes, age greater than 70 years, COPD, and dialysis were significant predictors (unadjusted) of mortality. Multiple comorbidities resulted in significant cumulative risk. The presence of 3 or more comorbidities was associated with a postoperative morbidity of 5.1% (p < 0.001) and mortality as high as 12.5%.
CONCLUSIONS: Thyroid surgery is generally safe. Common comorbidities significantly increase the risk of adverse outcomes and death. Clinically applicable risk calculation based on overall health may improve patient selection, surgical management, and informed consent.
Copyright © 2014 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24745620     DOI: 10.1016/j.jamcollsurg.2014.01.055

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Development and Feasibility of a Specialty-Specific National Surgical Quality Improvement Program (NSQIP): The Head and Neck-Reconstructive Surgery NSQIP.

Authors:  Carol M Lewis; Thomas A Aloia; Weiming Shi; Ira Martin; Stephen Y Lai; Jesse C Selber; Amy C Hessel; Matthew M Hanasono; Katherine A Hutcheson; Geoffrey L Robb; Randal S Weber
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-04       Impact factor: 6.223

2.  Energy vessel sealant devices are associated with decreased risk of neck hematoma after thyroid surgery.

Authors:  Katherine Moran; Areg Grigorian; Dawn Elfenbein; Sebastian Schubl; Zeljka Jutric; Michael Lekawa; Jeffry Nahmias
Journal:  Updates Surg       Date:  2020-04-24

3.  Ensemble machine learning for the prediction of patient-level outcomes following thyroidectomy.

Authors:  Carolyn D Seib; James P Roose; Alan E Hubbard; Insoo Suh
Journal:  Am J Surg       Date:  2020-12-03       Impact factor: 3.125

4.  Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program.

Authors:  Lisa Caulley; Stephanie Johnson-Obaseki; Lindy Luo; Hedyeh Javidnia
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

5.  Thyroidectomy in a Surgical Volunteerism Mission: Analysis of 464 Consecutive Cases.

Authors:  Rifat Latifi; Mahir Gachabayov; Shekhar Gogna; Renato Rivera
Journal:  J Thyroid Res       Date:  2019-11-28

6.  Can thyroidectomy be considered safe in obese patients? A retrospective cohort study.

Authors:  Gian Luigi Canu; Fabio Medas; Federico Cappellacci; Michele Guido Podda; Giorgio Romano; Enrico Erdas; Pietro Giorgio Calò
Journal:  BMC Surg       Date:  2020-11-07       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.